Capstone Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Capstone Asset Management's PFE Position: Q2 2017 in Review
Capstone Asset Management increased its Pfizer (PFE) stake by 79% in Q2 2017, buying an estimated $5.04M and bringing the position to 360,988 shares worth $11.5M. The position accounts for 0.32% of the portfolio, ranked #69.
Capstone Asset Management first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $27.2M in Q2 2013. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.
- Capstone Asset Management held 360,988 shares of Pfizer worth $11.5M as of Q2 2017.
- Capstone Asset Management bought 159,814 Pfizer shares in Q2 2017, an estimated $5.04M.
- Pfizer made up 0.32% of Capstone Asset Management's portfolio in Q2 2017, its #69 holding.
- Capstone Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
- Capstone Asset Management's Pfizer position peaked at $27.2M in Q2 2013.
- 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.